Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€3.05
12.04.22
€1.60
12.04.23
-30.60%
03.08.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.50
11.06.22
€1.90
11.06.23
-16.96%
03.08.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€12.13
11.07.22
€18.00
11.07.23
-12.93%
03.08.22

buy
Repligen Corp.

Start price
Target price
Perf. (%)
€210.00
03.08.21
-
03.08.22
13.21%
03.08.22

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.62
13.07.22
€7.00
13.07.23
-8.29%
02.08.22

Standard Investments for future growth
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Very capable Management
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€3.16
18.05.22
€15.00
18.05.23
292.41%
29.07.22

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
buy
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.38
29.07.21
-
28.07.22
-72.64%
29.07.22

Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.32
26.07.21
-
26.07.22
-48.82%
27.07.22

Risky Investment
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€1.66
26.07.21
-
26.07.22
-21.08%
27.07.22

Could be very worthwhile Investment >20% year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.87
18.07.22
-
18.07.23
-9.48%
23.07.22

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€613.40
10.07.22
€999.00
10.07.23
-6.06%
23.07.22

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€613.40
10.07.22
€999.00
10.07.23
-6.06%
23.07.22

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€613.40
10.07.22
€999.00
10.07.23
-6.06%
23.07.22

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€524.70
08.11.21
-
08.11.22
10.50%
21.07.22

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€524.70
08.11.21
-
08.11.22
10.50%
21.07.22

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€524.70
08.11.21
-
08.11.22
10.50%
21.07.22

Chemocentryx Inc.

Start price
Target price
Perf. (%)
€13.66
13.07.21
-
13.07.22
69.13%
14.07.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Sustainability is important
High valuation
buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€40.84
13.07.21
-
13.07.22
-62.81%
13.07.22

Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€2.91
15.06.22
-
15.06.23
8.65%
09.07.22

Risky Investment
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.50
03.07.22
-
03.07.23
8.30%
09.07.22

Risky Investment
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.35
07.07.22
-
07.07.23
-3.70%
09.07.22

Risky Investment
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.50
12.06.22
-
12.06.23
-26.05%
09.07.22

Could be very worthwhile Investment >20% year